also HN1 came along two months after recruitment ended in September 2023.
By contrast the Melbourne Heparin trial of Pfizers heparin sulphate antiviral nasal spray clearly crosses two variants with the call out for participants starting end august/begin Sept 2023 and to cross seasons probably continues for 12 months and catches the high proportion of HN1 occurring today and for next few months plus any other new variants
also HN1 came along two months after recruitment ended in...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.002(2.02%) |
Mkt cap ! $39.96M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.6¢ | $48.56K | 493.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 192364 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
9.8¢ |
Change
-0.002 ( 2.50 %) |
||||
| Open | High | Low | Volume | ||
| 9.9¢ | 10.0¢ | 9.6¢ | 118602 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| SPL (ASX) Chart |